ArticleContemporary clinical trials2025
A multi-site randomized clinical trial of socially assistive robots on engaging older adults with cognitive impairment residing in long-term care settings: A protocol paper.
Article in Contemporary clinical trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Apathy is common in persons with dementias, especially those in long-term care facilities (LTCs). Few pharmacologic options exist; a major strategy is to foster engagement in social, physical, and cognitive activities, but requires extensive personnel time. Non-immersive virtual environments (VE) combined with socially assistive robots (VE-SARs) can support LTC staff. We are conducting a randomized multi-site clinical trial to compare the effect of usual care (UC) to VE-SAR + UC on reducing apathy (primary outcome) among 188 older adults with cognitive impairment and enhancing executive cognitive function (secondary outcome). Eligibility of state-licensed LTCs include an hour's drive from the principal investigators' offices, activity personnel willing to interact with research staff, certified by the U.S. Centers for Medicare and Medicaid, and physical space for equipment storage and robot set-up. Eligibility for older adults include age ≥ 60 years, LTC residance >3 months, evidence of mild cognitive impairment or dementia, and symptoms of apathy. Older adults randomized to VE-SAR + UC are paired and participate in twice-weekly sessions for 8 weeks. Staff are interviewed using the Apathy Evaluation Scale-Clinician for apathy ratings. Older adults are interviewed on executive cognitive function using the Trail Making Tests A and B and Animal Naming Test. Data are collected at baseline, Week 4, and Week 8. Field notes are taken throughout and sessions are videorecorded. We will use mixed-effects linear modeling for repeated measures to model apathy as a function of fixed-effects of intervention (VE-SAR + UC vs. UC), time, and intervention by time interaction, adjusting for covariates (e.g., baseline cognitive function).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.